Literature DB >> 9767996

[Extrapulmonary tuberculosis in the central western region. Retrospective study of 217 cases (Gericco 1991-1993)].

N Denis-Delpierre1, D Merrien, E Billaud, J M Besnier, E Duhamel, P Hutin, F Andrieux, C Delaunay, J P Rogez, P Arsac, J M Chennebault, F Raffi.   

Abstract

OBJECTIVES: To analyze the epidemiological, clinical and diagnostic characteristics of extrapulmonary tuberculosis in western France observed from 1991 to 1993 in different patients populations (HIV+ infected patients, immunosuppressed non-HIV infected patients, non-immunosuppressed patients) and according to various localizations (lymph nodes, bone and joints, genital organs, nervous system and meninges, miliary disease).
METHODS: This retrospective study included 217 cases of extrapulmonary tuberculosis diagnosed from 1991 to 1993 in western France by GERICCO (Groupe d'Epidémiologie et de Recherche en Infectiologie Clinique du Centre-Ouest). Demographic, clinical, biological, microbiological and radiographic characteristics as well as clinical course on specific therapy were assessed.
RESULTS: Extrapulmonary tuberculosis generally occurred most often in immunosuppressed patients but 34% of cases were observed in people without any underlying disease or risk factors. Delay to diagnosis was especially long in the non-immunosuppressed patients (mean = 96 days) but shorter in the HIV-infected patients (mean = 59 days). It was shorter in case of nervous system involvement (mean = 52 days) or military disease (mean = 80 days) than in bone and joints (mean = 120 days) and lymph nodes (mean = 102 days). Microbiologically proven tuberculosis represented only 75% of cases despite numerous investigations. Overall prognosis was good except in nervous system and meninges localizations. Failures were mainly due to death in immunosuppressed patients.
CONCLUSION: Extrapulmonary tuberculosis remains frequent even in patients lacking risk factors. In 50% of cases, confirmation of diagnosis takes more than one month. In case of doubt, clinicians should not wait for laboratory results before implementing empirical specific therapy.

Entities:  

Mesh:

Year:  1998        PMID: 9767996

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  5 in total

1.  Tuberculous vertebral osteomyelitis in the new millennium: still a diagnostic and therapeutic challenge.

Authors:  J D Colmenero; M E Jiménez-Mejías; J M Reguera; J Palomino-Nicás; J D Ruiz-Mesa; J Márquez-Rivas; A Lozano; J Pachón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-26       Impact factor: 3.267

2.  The Clinical Features and Bacteriological Characterizations of Bone and Joint Tuberculosis in China.

Authors:  Su-Ting Chen; Li-Ping Zhao; Wei-Jie Dong; Yun-Ting Gu; Yun-Xu Li; Ling-Ling Dong; Yi-Feng Ma; Shi-Bing Qin; Hai-Rong Huang
Journal:  Sci Rep       Date:  2015-06-08       Impact factor: 4.379

3.  Diagnostic efficiency of Xpert MTB/RIF assay for osteoarticular tuberculosis in patients with inflammatory arthritis in China.

Authors:  Yuan Li; Wenyun Jia; Guohua Lei; Dan Zhao; Guirong Wang; Shibing Qin
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

4.  [Abdominal pseudotumoral tuberculosis].

Authors:  Rachid El Barni; Mohamed Lahkim; Abdessamad Achour
Journal:  Pan Afr Med J       Date:  2012-10-15

5.  Rapid differential diagnosis between extrapulmonary tuberculosis and focal complications of brucellosis using a multiplex real-time PCR assay.

Authors:  María Isabel Queipo-Ortuño; Juan D Colmenero; Pilar Bermudez; María José Bravo; Pilar Morata
Journal:  PLoS One       Date:  2009-02-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.